News on Tuesday that Amazon was forming a new company with JPMorgan Chase and Warren Buffett’s big-pocketed Berkshire Hathaway sent shock waves through the health care industry.
HealthCare.gov enrollment reached nearly 95 percent of last year's level, outperforming projections in a show of consumer demand, despite a shortened sign-up season and big cuts in the ad budget.
High-deductible health plans are booming in popularity, but, in an effort to save money, too many people are skipping preventive care even though such visits are covered 100 percent.
The National Business Group on Health is projecting the total cost of providing medical and pharmacy benefits to increase 5 percent for the fifth consecutive year in 2018.
Without dozens of insurance claims to file and follow up, physicians cut administrative overhead, reduce costs and keep their practices limited to a few hundred patients, rather than a few thousand.
Indiana hospitals are bracing for congressional action that could mean deep cuts in Medicaid, which funds the state’s popular health insurance program for low-income adults.
In the latest sign of health care consolidation, Indiana’s largest independent physician group has agreed to be acquired by the nation’s largest health insurer for $184 million.
Indiana officials are sounding alarm bells about a plan by Republicans in Congress to cut Medicaid spending.
In Lilly’s partnership with Harvard Pilgrim Health Care, the not-for-profit insurer gets additional rebates if fewer patients using Lilly's diabetes treatment Trulicity meet blood sugar goals than expected.
The Trump administration and its pick to lead the Centers for Medicare & Medicaid Services are likely to champion the approach behind HIP 2.0—a Medicaid expansion that requires those receiving insurance coverage to have "skin in the game" by contributing financially.
For years, medical-device makers in Indiana and around the nation have insisted that the 2.3 percent tax on sales to help fund the Affordable Care Act has hurt business and slowed innovation.
Anthem Inc. fired back against U.S. claims that the health insurer’s planned $48 billion takeover of rival Cigna Corp. will undermine competition.
For patients, the difference between getting an operation now or in January could amount to thousands of dollars out of pocket.
The company's top-selling product, the insulin Humalog, saw U.S. sales by volume rise 10 percent in the third quarter. But because of rebates and other discounts, revenue dropped 14 percent.
Starting Jan. 1, any health care organization that takes federal money for health purposes can’t refuse to provide transgender services.